Fennec Pharmaceuticals In... (FENC)

AI Score

Unlock

5.19

-0.40 (-7.16%)

At close: Apr 04, 2025, 3:16 PM

Fennec Pharmaceuticals Cash Flow Statement

Chart Mode

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006	FY 2005	FY 2004	FY 2003	FY 2002	FY 2001	FY 2000
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007	Dec 31, 2006	Dec 31, 2005	Jun 30, 2004	Jun 30, 2003	Jun 30, 2002	Jun 30, 2001	Jun 30, 2000
Net Income	-70K	-16.05M	-23.71M	-17.35M	-18.11M	-12.78M	-9.89M	-7.05M	-2.79M	-659K	-2.18M	1.84M	-5.16M	4.68M	-7.82M	-3.01M	-13.6M	-13.36M	-19.1M	-19.25M	-8.74M	-6.15M	-3.72M	-2.45M	-1.6M
Depreciation & Amortization	800K	n/a	132K	14K	402K	64K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	164K	192K	2.43M	3.06M	2.52M	1.61M	123.76K	55.23K	52.01K
Stock-Based Compensation	5.06M	5.35M	4.22M	4.01M	2.88M	3.08M	1.82M	1.52M	615K	97K	627K	87K	326K	250K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Working Capital	n/a	819.83K	1.61M	-138K	-722K	-11K	-45K	402K	64K	-52K	24K	-365K	n/a	n/a	n/a	n/a	119K	-2.46M	2.12M	1M	605.48K	n/a	n/a	n/a	351.85K
Other Non-Cash Items	21.19M	326K	334K	307K	486K	481K	105K	875K	40K	-1.24M	-270K	-3.78M	1.56M	-8.08M	5.78M	213K	2.49M	2.32M	2.61M	2.93M	-376.3K	-313.29K	n/a	0.00	-30.39K
Deferred Income Tax	n/a	n/a	n/a	-14K	-402K	-64K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-1.53M	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	n/a	-6.78M	1.1M	-932K	-763K	569K	132K	1.01M	10K	-63K	120K	-365K	280K	-81K	116K	-1.89M	134K	-2.46M	2.12M	1M	605.48K	-578.33K	366.82K	-289.04K	351.85K
Operating Cash Flow	26.98M	-17.14M	-18.06M	-14.22M	-15.6M	-9.06M	-7.83M	-3.64M	-2.12M	-1.86M	-1.7M	-2.21M	-2.99M	-3.23M	-1.93M	-4.69M	-10.81M	-13.3M	-13.47M	-12.26M	-5.99M	-5.43M	-3.23M	-2.69M	-1.22M
Capital Expenditures	n/a	2.75	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-15K	-73K	-5K	-102K	-155.12K	-69.79K	-298.72K	-331.6K	-32.32K
Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-3.44M	-7.11M	n/a	-5.37M	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.18M	2.26M	n/a	6.04M	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	24K	-15K	-2K	1.17M	22K	193.15K	-861.93K	-130.1K	8.4K	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	24K	-15K	-75K	1.17M	-1.25M	-7.07M	5.11M	-5.8M	-323.2K	-32.32K
Debt Repayment	-13M	5M	19.93M	5M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-40K	28K	-59K	n/a	1.3M	1.93M	-32.97K	-24.29K
Common Stock Repurchased	n/a	-78K	-194K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-615K	1.64M	797K	-22K	322K	-71K	2.35M	594K	108K	497K	161K	n/a	n/a	n/a	n/a	n/a	7K	n/a	-70K	-141K	24.56M	-377.3K	-0.41	n/a	0.09
Financial Cash Flow	-13.62M	6.64M	20.73M	4.98M	32.29M	-71K	2.35M	27.98M	5.11M	497K	2.34M	1.57M	n/a	2.57M	7.19M	n/a	7K	23.88M	6.05M	7.96M	24.56M	2.24M	-33.34K	12.25M	1.28M
Net Cash Flow	13.37M	-10.51M	2.67M	-9.24M	16.69M	-9.13M	-5.48M	24.33M	2.98M	-1.36M	644K	-640K	-2.99M	-650K	5.26M	-4.66M	-10.81M	10.5M	-6.25M	-5.56M	11.5M	1.92M	-9.06M	9.24M	24.33K
Free Cash Flow	26.98M	-17.14M	-18.06M	-14.22M	-15.6M	-9.06M	-7.83M	-3.64M	-2.12M	-1.86M	-1.7M	-2.21M	-2.99M	-3.23M	-1.93M	-4.69M	-10.82M	-13.38M	-13.48M	-12.36M	-6.14M	-5.5M	-3.53M	-3.02M	-1.26M